Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44

Introduction

Hepatocellular carcinoma (HCC) occurs in the liver and is related to infection by hepatitis B or C virus (1). HCC cells maintain their proliferative potential in fibrous tissues with limited amounts of glucose and arginine (2), despite glucose being indispensable for cell survival (3). Hepatocytes produce energy from galactose via glycolysis (4,5) and arginine is an essential amino acid in this process (6). Hepatocytes produce arginine from ornithine via the urea cycle. Hepatocyte selection medium (HSM) is deficient in glucose and arginine, and is supplemented with galactose and ornithine (7). HSM enriches hepatocytes from co-culture with human induced pluripotent stem cells (8). HSM is also applicable to a condition similar to fibrous tissues (9).

α-fetoprotein (AFP) is a marker of immature hepatocytes (10). HCC cells are immature hepatocytes and produce AFP (11,12). CD44 is a receptor of hyaluronan (13) and is used as a marker of cancer stem cells (14). In a previous study, CD44 was not identified to be expressed in surgical specimens of HCC because the presence of cancer stem cells is rare (15). In another previous study, HCC cells were demonstrated to be heterogeneously positive for AFP and CD44 (16). These studies suggest that the positivity of CD44 in HCC cells remains controversial. Alterations in the expression patterns of AFP and CD44 are not known in HCC cells cultured without glucose or arginine.

Therefore, in the present study, the expression patterns of AFP and CD44 were investigated in HCC cells cultured in HSM to examine the alterations in the characteristics of HCC cells grown in the absence of glucose and arginine.

Materials and methods

Cell culture and determination of cell numbers

The HCC cell lines HLF and PLC/PRF/5 cells (RIKEN Cell Bank, Tsukuba, Japan) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific, Inc., Waltham, MA, USA) in 6-well plates (AGC Techno Glass Co., Ltd., Shizouka, Japan) at 37°C in a humidified chamber containing 5% CO2. Cells (1×104) were spread onto each well of the 6-well plates, and viable cell numbers were determined on days 0 and 7 following culture using the trypan blue dye exclusion test.

Hepatocyte selection medium

HSM was prepared from amino acid powders, using the formulation of Leibovitz L-15 medium (Thermo Fisher Scientific, Inc.), omitting arginine, tyrosine, glucose and sodium pyruvate, but with the addition of 900 mg/l galactose, 1 mM ornithine, 5 mM glycerol and 260 mM proline (all Wako Pure Chemical Industries, Osaka, Japan). Proline was included in the medium as it is required for DNA synthesis (17). Knockout serum replacement (Thermo Fisher Scientific, Inc.) was used in place of FBS to establish defined xenobiotic-free conditions and was added at a final concentration of 10%.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Cells were cultured in DMEM or HSM in 6-well plates. On days 0, 4 and 7, RNA was isolated using Isogen (Nippon Gene Co., Ltd., Tokyo, Japan). Total RNA (5 µg) was subjected to cDNA synthesis using a SuperScript III First-Strand Synthesis system (Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. qPCR was performed using Fast SYBR Green Master Mix (Thermo Fisher Scientific, Inc.) with the MiniOpticon (Bio-Rad Laboratories, Inc., Hercules, CA, USA) for 40 cycles consisted of two steps of denaturation at 95°C for 5 sec and annealing-extension at 60°C for 5 sec. Table I lists the primer sequences used. Ribosomal protein L19 (RPL19), a constitutively expressed housekeeping gene, was used as an internal control (18). RPL19 was used as an endogenous control to monitor the amount of mRNA because the gene is a constitutively expressed housekeeping gene (18). The expression levels of the genes were analyzed automatically by the Mini Opticon system (Bio-Rad Laboratories, Inc.) based on delta-delta cycle quantification (ΔΔCq) method (19). Relative expression level of a gene was calculated as expression level of a gene divided by expression level of RPL19.

Table I. Sequences of primers used in the quantitative polymerase chain reaction.

Table I.

Sequences of primers used in the quantitative polymerase chain reaction.

Primer name	Sequence	Description	Product size (bp)	GenBank® accession no.
OMC317	5-ACACAAAAAGCCCACTCCAG-3′	AFP, forward	147	NM_001134
OMC318	5′-GGTGCATACAGGAAGGGATG-3′	AFP, reverse	147
OMC321	5′-CGAATGCCAGAGAAGGTCAC-3′	RPL19, forward	157	BC095445
OMC322	5′-CCATGAGAATCCGCTTGTTT-3′	RPL19, reverse	157
OMC755	5′-AGAAGGTGTGGGCAGAAGAA-3′	CD44, forward	116	BC004372
OMC756	5′-AAATGCACCATTTCCTGAGA-3′	CD44, reverse

[i] AFP, α-fetoprotein; RPL19, ribosomal protein L19; CD44, cluster of differentiation 44.

Immunostaining

HLF and PLC/PRF/5 cells were spread onto 8-well chamber slides (Matsunami Glass Ind., Ltd., Kishiwada, Japan). The cells were cultured in DMEM or HSM. Following 7 days of culture, the cells were fixed with 4% paraformaldehyde (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 30 min at 4°C. Endogenous peroxidase was inactivated by incubation with 0.1% hydrogen peroxide in 100% methanol for 30 min at 4°C. Specimens were incubated with 2% fetal bovine serum in PBS (wash buffer) at 4°C for 30 min. Specimens were incubated with mouse anti-human AFP (catalog no. M225) (Takara Bio, Inc., Otsu, Japan) or mouse anti-human CD44 (catalog no. 3570s; Cell Signaling Technology, Inc., Danvers, MA, USA) antibody diluted 1:1,000 in wash buffer overnight at 4°C. Specimens were rinsed with PBS three times, and incubated with a 1:1,000 dilution of horseradish peroxidase-labeled anti-mouse antibody (catalog no. NA934-100UL; GE Healthcare Bio-Sciences, Pittsburg, PA, USA) at 4°C for 3 h. Diaminobenzidine (Dako; Agilent Technologies, Inc., Santa Clara, CA, USA) was applied, and the nuclei were stained with hematoxylin (Muto Pure Chemicals Co., Ltd., Tokyo, Japan) for 15 sec. Specimens were observed and images were captured using an AX80 photomicroscope (Olympus Corporation, Tokyo, Japan).

Statistical analysis

A one-way analysis of variance was applied for statistical analysis using JMP software (version 10.0.2; SAS Institute, Cary, NC, Inc.), and Tukey's test was used as a post hoc test. P<0.05 was considered to indicate a statistically significant difference.

Results

To determine the effects of HSM on cell proliferation, the number of HLF (Fig. 1A) and PLC/PRF/5 (Fig. 1B) viable cells were determined following culture in DMEM or HSM. Viable cell numbers were observed to increase towards day 7 of culture in DMEM, whereas a decrease in viable cell number was observed towards day 7 of culture in HSM. Viable cell numbers were significantly increased following culture in DMEM compared with culture in HSM. These results suggest that HMS significantly decreased cell proliferation.

Figure 1. Viability of cells cultured in two separate media. (A) HLF and (B) PLC/PRF/5 cells were cultured in Dulbecco's modified Eagle's medium (unbroken line) or hepatocyte selection medium (broken line). Viability of cells was determined using a trypan blue assay at days 0 and 7. *P<0.05 vs. culture in HSM at day 7.

The mRNA expression levels of AFP (Fig. 2A) and CD44 (Fig. 2B) were analyzed using RT-qPCR. The expression levels of AFP and CD44 were significantly increased on day 7 in HLF and PLC/PRF/5 cells (P<0.05; Fig. 2). These results suggest that HSM upregulated the expression of AFP and CD44.

Figure 2. Expression levels of AFP and CD44. HLF (unbroken line) and PLC/PRF/5 (broken line) cells were cultured in hepatocyte selection medium. RNA was isolated and subjected to the reverse transcription-quantitative polymerase chain reaction to analyze the expression levels of (A) AFP and (B) CD44. *P<0.05 vs. expression at day 0. AFP, α-fetoprotein; CD44, cluster of differentiation 44.

The expression levels of AFP and CD44 proteins were analyzed by immunostaining. The expression of AFP was identified to increase in HLF cells between day 0 (Fig. 3A) and day 7 (Fig. 3B), whereas its expression in PLC/PRF/5 cells did not appear to alter during this same timeframe (Fig. 3C and D). The expression level of CD44 was also increased in HLF cells between day 0 (Fig. 3E) and day 7 (Fig. 3F), but was not apparently altered in PLC/PRF/5 cells (Fig. 3G and H).

Figure 3. Immunostaining. HLF cells cultured in (A) DMEM or (B) HSM, or PLC/PRF/5 cells cultured in (C) DMEM or (D) HSM were subjected to immunostaining with an anti-AFP antibody. HLF cells cultured in (E) DMEM or (F) HSM, or PLC/PRF/5 cells cultured in (G) DMEM or (H) HSM were subjected to immunostaining with an anti-CD44 antibody. Scale bar, 100 µm. DMEM, Dulbecco's modified Eagle's medium; HSM, hepatocyte selection medium; AFP, α-fetoprotein; CD44, cluster of differentiation 44.

Discussion

Stem cells of HCC cloned with CD34 express AFP and CD44 (20). AFP is expressed by HCC cells through dedifferentiation (21). These studies suggest that HCC cells positive for AFP and CD44 are markers of cancer stem cells of HCC. In the present study, the expression levels of AFP and CD44 were identified to increase following incubation in HSM. To the best of our knowledge, there are currently no reported studies on the culture of HCC cells in media lacking glucose. The biological significance of the results of the present study is unclear; however, there are two possibilities. One is that the transcriptional activity of the AFP and CD44 genes was activated. The other is that cancer stem cells were purified with HSM. To determine which hypothesis may be true, the promoter activities of AFP and CD44 should be analyzed. HCC cells positive for AFP exhibit the characteristics of cancer stem cells and are associated with poor prognosis (22,23). The results of these previous studies and those of the present study suggest that HCC cells enriched in HSM have stem cell-like characteristics. Suppressing the expression of CD44 may be useful as a treatment for cells cultured in HSM (24).

The cancer microenvironment is typically lacking in glucose because the supply of glucose to the tumor is not sufficient (25,26). In the present study, HCC cells were cultured in HSM, a medium deficient in glucose, to mimic the microenvironment of cancer. HSM was identified to be potentially useful to create an experimental cancer microenvironment model, such as fibrous tissues surrounding HCC (2). The results of the present study suggest that cancer stem cells from HCC were enriched in HSM, which is a potentially useful medium to enrich cancer stem cells from HCC.

A limitation of the present study was that the resultant cells cultured in HSM may not definitively be classified as stem cells. It is possible that these cells only have partial cancer stem cell characteristics.

In future studies, cells obtained from culture in HSM require propagation and investigation for cancer stem cell characteristics including analysis of cell-surface markers and spheroid formation assay (27,28).

The results of the present study identified that HSM decreased the number of HCC cells, but the expression levels of AFP and CD44 were increased in the cells obtained from culture in HSM. Therefore, HSM is potentially useful for the enrichment of stem cells of HCC.

Acknowledgements

The present study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (grant no. 15K09032).

References